Aryse Health Launches in India, Bringing a New Model of Proactive, Precision-Led Healthcare to Bengaluru
Bengaluru: What if a health check-up didn’t end with a diagnosis?What if, instead of waiting for something to go wrong, healthcare could identify the patterns that may be quietly changing years earlier and give people a way to act on them?
That is the thinking behind Aryse Health, which has launched in India with its first clinic in Indiranagar, Bengaluru. Aryse is a doctor-led, science-based health optimisation facility designed around a simple premise: healthcare should not only treat disease, but also help people understand and protect their health during the years before disease becomes the defining conversation. Aryse calls this the preventive window, the space between conventional sick care and the wellness industry, where measurable changes in health may already be underway, but before they necessarily become symptoms or a diagnosis.
Rather than offering another annual health check-up or a wellness experience built primarily around how one feels, Aryse takes a continuous approach to health. Its optiME membership begins with an in-depth assessment of an individual’s biology using 200+ blood markers, DEXA, VisBody and other diagnostics, creating a detailed baseline across areas including metabolic health, cardiovascular risk, body composition, sleep and recovery, cognitive health and biological ageing. The difference lies in what happens next.Data is processed through Resolute AI, Aryse’s intelligence platform, which is designed to identify patterns and subtle trends across an individual’s health data and cross-reference them against longevity protocols. This intelligence layer then works alongside a multidisciplinary clinical team to develop a personalised programme.
The model is built around three continuous stages: Measure. Monitor. Mitigate.Members move from entry diagnostics to a personalised protocol, ongoing engagement and quarterly reassessment, allowing the care team to track what is changing and adjust the programme accordingly. A dedicated Engagement Manager supports the member through the journey, while clinicians and specialists work from a shared plan rather than operating in silos.
“We have become very good at treating disease, managing emergencies and healthcare tends to become a reactive mechanism only after something is wrong,” says Dr. Gurmeet Soni Bhalla, CEO and CMO, Aryse Health. “At Aryse, we are interested in the years before that point, the period when the body is changing, often quietly, and when there is still an opportunity to understand those changes and act on them. Our goal is to bring medical rigour, technology and continuous care together so that health becomes something people actively manage, not something they think about only when a report raises a red flag.”
Aryse’s approach goes beyond a single health metric. Its care ecosystem brings together specialists across metabolic health, hormone health, women’s health, functional medicine, lifestyle and nutrition, supported by a coordinated care model. The platform also offers focused Health Journeys for specific needs, including metabolic and fat loss, women’s hormonal health, men’s hormonal health and gut restoration. For members requiring more targeted intervention, Aryse’s Precision Suite includes customised protocols and, where clinically appropriate, offerings such as IV infusions, ExoMind, peptide therapy, HRT and longevity pharmaceuticals. These interventions sit within the broader clinical framework rather than being offered as standalone wellness treatments.
At the centre of the Aryse philosophy is personalisation. The platform does not prescribe a universal “longevity protocol”; instead, programmes are designed around an individual’s biology, risk profile and measurable outcomes. Every plan is expected to be evidence-led, personalised, monitored and adjusted based on results. Dr. Bhalla brings more than two decades of clinical experience to Aryse, with expertise spanning paediatrics, allergy and clinical immunology, and a growing focus on preventive health and longevity. As CEO and CMO of Aryse, she leads a model that seeks to bring together clinical medicine, diagnostics, technology and long-term health optimisation.
With its Bengaluru launch, Aryse enters a rapidly evolving healthcare landscape where consumers are becoming increasingly interested not only in living longer, but in understanding how they are ageing and how many of those years can be spent healthy, active and high-performing. For Aryse, longevity is therefore not a destination or a single treatment. It is an ongoing healthcare relationship, built around better data, better decisions and the ability to intervene earlier.
